Bank of New York Mellon’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bank of New York Mellon’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,144	Closed	-$15K	–	4613
2022 Q2	$15K	Sell	15,144 -43,674	-74%	-$57.6K	﹤0.01%	4525
2022 Q1	$113K	Hold	58,818	–	–	﹤0.01%	4385
2021 Q4	$129K	Hold	58,818	–	–	﹤0.01%	4365
2021 Q3	$219K	Hold	58,818	–	–	﹤0.01%	4178
2021 Q2	$352K	Buy	58,818 +16,231	+38%	+$85.8K	﹤0.01%	3915
2021 Q1	$280K	Sell	42,587 -1,493	-3%	-$9.81K	﹤0.01%	3937
2020 Q4	$249K	Sell	44,080 -1,181	-3%	-$6.48K	﹤0.01%	3904
2020 Q3	$213K	Buy	45,261 +2	+0%	+$14	﹤0.01%	3830
2020 Q2	$526K	Buy	45,259 +31,956	+240%	+$379K	﹤0.01%	3444
2020 Q1	$77K	Sell	13,303 -142	-1%	-$1.27K	﹤0.01%	3903
2019 Q4	$184K	Hold	13,445	–	–	﹤0.01%	3936
2019 Q3	$101K	Hold	13,445	–	–	﹤0.01%	4026
2019 Q2	$81K	Hold	13,445	–	–	﹤0.01%	4060
2019 Q1	$95K	Buy	+13,445	New	+$70.1K	﹤0.01%	4015
2018 Q4	–	Sell	-3,343	Closed	-$28K	–	4305
2018 Q3	$28K	Sell	3,343 -224	-6%	-$2.36K	﹤0.01%	4189
2018 Q2	$43K	Sell	3,567 -15,724	-82%	-$162K	﹤0.01%	4114
2018 Q1	$191K	Sell	19,291 -173	-0.9%	-$1.95K	﹤0.01%	3938
2017 Q4	$257K	Sell	19,464 -6,053	-24%	-$77.9K	﹤0.01%	3860
2017 Q3	$375K	Buy	25,517 +142	+0.6%	+$14.3K	﹤0.01%	3687
2017 Q2	$2.66M	Sell	25,375 -2,000	-7%	-$215K	﹤0.01%	2678
2017 Q1	$3.51M	Buy	27,375 +4,778	+21%	+$504K	﹤0.01%	2514
2016 Q4	$2.02M	Buy	22,597 +5,096	+29%	+$386K	﹤0.01%	2848
2016 Q3	$1.29M	Sell	17,501 -260	-1%	-$18.8K	﹤0.01%	3039
2016 Q2	$1.18M	Buy	17,761 +1,746	+11%	+$99.3K	﹤0.01%	3034
2016 Q1	$771K	Buy	16,015 +1,510	+10%	+$80.1K	﹤0.01%	3218
2015 Q4	$1.08M	Buy	14,505 +1,492	+11%	+$100K	﹤0.01%	3127
2015 Q3	$899K	Sell	13,013 -2,147	-14%	-$201K	﹤0.01%	3245
2015 Q2	$1.39M	Buy	15,160 +5,616	+59%	+$569K	﹤0.01%	3152
2015 Q1	$1.05M	Buy	9,544 +4,104	+75%	+$482K	﹤0.01%	3277
2014 Q4	$733K	Buy	5,440 +864	+19%	+$101K	﹤0.01%	3466
2014 Q3	$521K	Buy	4,576 +244	+6%	+$32.3K	﹤0.01%	3606
2014 Q2	$728K	Buy	+4,332	New	+$748K	﹤0.01%	3477

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon's ARAV Position: Q3 2022 in Review

Bank of New York Mellon sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2022, closing a stake of 15,144 shares — an estimated $15K sold.

Bank of New York Mellon first reported a position in ARAV in Q2 2014 and held it in 32 quarters. The position peaked at $3.51M in Q1 2017. 28 funds tracked by Wall St. Rank hold ARAV as of Q3 2022.

Bank of New York Mellon reported no remaining Aravive, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Bank of New York Mellon sold 15,144 Aravive, Inc. Common Stock shares in Q3 2022, an estimated $15K.
Bank of New York Mellon first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 32 quarters.
Bank of New York Mellon's Aravive, Inc. Common Stock position peaked at $3.51M in Q1 2017.
28 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2022.

Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.